Tweet
call_for_abstracts.jpgThe Gait and Clinical Movement Analysis Society (GCMAS) invites your participation in the 2026 Annual Meeting, to be held June 9–13 at the Creighton University Health Sciences Campus in Phoenix, Arizona, USA. Abstracts will be selected for the 2026 scientific program through a competitive, peer-review process. The 2026 Program Committee invites submissions in all areas of gait and clinical movement analysis, including:
The Abstract Submission System is open and will close on January 10, 2026. An Early Decision option is available for abstracts submitted on or before December 12, 2025.
Please visit https://na.eventscloud.com/website/87479/abstracts for additional information and to submit an abstract.
Guidelines for Scientific Studies:
Abstracts describing original research should be comprised of the following sections: Introduction, Clinical Significance, Methods, Results, Discussion, References, Acknowledgments, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size.
Guidelines for Clinical Case Studies:
Abstracts describing clinical case studies should be comprised of the following sections: Subject History, Clinical Data, Motion Data, Treatment Decisions and Indications, Outcome (if available) Summary, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should illustrate the value of motion analysis and/or modeling in the evaluation, understanding, and/or treatment of a movement disorder. Priority will be given to studies that include pre- and post-treatment data.
Guidelines for New Tools and Techniques:
Abstracts describing methodological advances should be comprised of the following sections: Introduction, Clinical Significance, Methods, Demonstration, Summary, References, Acknowledgments, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should describe novel methods (i.e., devices or algorithms) that enhance our ability to visualize, measure, or analyze the mechanics, tendons, joints, and/or limb segments. Abstracts from vendors will be considered but must not contain promotional material.
- AI in clinical movement analysis
- Balance/Stability/Posture
- Data and Analysis Methods
- Foot and Ankle
- Gait Analysis
- Markerless motion capture
- Muscles/FES/EMG
- Normal Motion
- Novel Biomechanics
- Orthopaedics
- Pathological Motion
- Prosthetics/Orthotics/Assistive Devices
- Quality Service Delivery and Standards
- Rehabilitation
- Sports and Sports Performance
- Trunk and Upper Extremity
- Wearables
The Abstract Submission System is open and will close on January 10, 2026. An Early Decision option is available for abstracts submitted on or before December 12, 2025.
Please visit https://na.eventscloud.com/website/87479/abstracts for additional information and to submit an abstract.
Guidelines for Scientific Studies:
Abstracts describing original research should be comprised of the following sections: Introduction, Clinical Significance, Methods, Results, Discussion, References, Acknowledgments, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size.
Guidelines for Clinical Case Studies:
Abstracts describing clinical case studies should be comprised of the following sections: Subject History, Clinical Data, Motion Data, Treatment Decisions and Indications, Outcome (if available) Summary, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should illustrate the value of motion analysis and/or modeling in the evaluation, understanding, and/or treatment of a movement disorder. Priority will be given to studies that include pre- and post-treatment data.
Guidelines for New Tools and Techniques:
Abstracts describing methodological advances should be comprised of the following sections: Introduction, Clinical Significance, Methods, Demonstration, Summary, References, Acknowledgments, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should describe novel methods (i.e., devices or algorithms) that enhance our ability to visualize, measure, or analyze the mechanics, tendons, joints, and/or limb segments. Abstracts from vendors will be considered but must not contain promotional material.